Bucaramanga, January 2022. Two years after the beginning of the pandemic due to COVID-19, Fundación Cardiovascular de Colombia has established itself as the Latin American institution that has treated more patients with extracorporeal membrane oxygenation (ECMO): more than 200 people have accessed this technology that can replace artificially and temporarily the function of the lungs.